Literature DB >> 30381460

Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.

Lei Shi1,2,3, Kang Li1,2,3, Yizhan Guo2,3, Anirban Banerjee2,3, Qing Wang2,3, Ulrike M Lorenz3,4, Mahmut Parlak3,4, Lucy C Sullivan5, Oscar Okwudiri Onyema2,3, Saeed Arefanian6, Edward B Stelow7, David L Brautigan7, Timothy N J Bullock3,7, Michael G Brown3,8, Alexander Sasha Krupnick9,3.   

Abstract

Natural killer (NK) cells play a critical role in controlling malignancies. Susceptibility or resistance to lung cancer, for example, specifically depends on NK cell function. Nevertheless, intrinsic factors that control NK cell-mediated clearance of lung cancer are unknown. Here we report that NK cells exposed to exogenous major histocompatibility class I (MHCI) provide a significant immunologic barrier to the growth and progression of malignancy. Clearance of lung cancer is facilitated by up-regulation of NKG2D, NKp46, and other activating receptors upon exposure to environmental MHCI. Surface expression of the inhibitory receptor Ly49C/I, on the other hand, is down-regulated upon exposure to tumor-bearing tissue. We thus demonstrate that NK cells exhibit dynamic plasticity in surface expression of both activating and inhibitory receptors based on the environmental context. Our data suggest that altering the activation state of NK cells may contribute to immunologic control of lung and possibly other cancers.

Entities:  

Keywords:  NK cells; immunosurveillance; immunotherapy; lung cancer; tumor immunology

Mesh:

Substances:

Year:  2018        PMID: 30381460      PMCID: PMC6243255          DOI: 10.1073/pnas.1804931115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.

Authors:  Ariella Glasner; Hormas Ghadially; Chamutal Gur; Noa Stanietsky; Pinchas Tsukerman; Jonatan Enk; Ofer Mandelboim
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

Review 2.  Self-tolerance of natural killer cells.

Authors:  David H Raulet; Russell E Vance
Journal:  Nat Rev Immunol       Date:  2006-07       Impact factor: 53.106

3.  A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education.

Authors:  Anick Chalifour; Léonardo Scarpellino; Jonathan Back; Petter Brodin; Estelle Devèvre; Frédéric Gros; Frédéric Lévy; Georges Leclercq; Petter Höglund; Friedrich Beermann; Werner Held
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

4.  Influence of natural killer cells and perforin‑mediated cytolysis on the development of chemically induced lung cancer in A/J mice.

Authors:  Manuela Frese-Schaper; Andreas Keil; Hideo Yagita; Selina Katja Steiner; Werner Falk; Ralph Alexander Schmid; Steffen Frese
Journal:  Cancer Immunol Immunother       Date:  2014-06       Impact factor: 6.968

5.  CD8 is needed for development of cytotoxic T cells but not helper T cells.

Authors:  W P Fung-Leung; M W Schilham; A Rahemtulla; T M Kündig; M Vollenweider; J Potter; W van Ewijk; T W Mak
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

6.  Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.

Authors:  Daniel M Andrews; Lucy C Sullivan; Nikola Baschuk; Christopher J Chan; Richard Berry; Claire L Cotterell; Jie Lin; Heloise Halse; Sally V Watt; Jennifer Poursine-Laurent; Chyung-Ru Wang; Anthony A Scalzo; Wayne M Yokoyama; Jamie Rossjohn; Andrew G Brooks; Mark J Smyth
Journal:  Nat Immunol       Date:  2012-11-11       Impact factor: 25.606

7.  Determinants of antileukemia effects of allogeneic NK cells.

Authors:  Wing Leung; Rekha Iyengar; Victoria Turner; Peter Lang; Peter Bader; Paul Conn; Dietrich Niethammer; Rupert Handgretinger
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

8.  Natural killer cell licensing in mice with inducible expression of MHC class I.

Authors:  Takashi Ebihara; A Helena Jonsson; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

9.  Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment.

Authors:  Nathalie T Joncker; Nataliya Shifrin; Frédéric Delebecque; David H Raulet
Journal:  J Exp Med       Date:  2010-09-06       Impact factor: 14.307

10.  Cancer immunoediting by the innate immune system in the absence of adaptive immunity.

Authors:  Timothy O'Sullivan; Robert Saddawi-Konefka; William Vermi; Catherine M Koebel; Cora Arthur; J Michael White; Ravi Uppaluri; Daniel M Andrews; Shin Foong Ngiow; Michele W L Teng; Mark J Smyth; Robert D Schreiber; Jack D Bui
Journal:  J Exp Med       Date:  2012-08-27       Impact factor: 14.307

View more
  12 in total

1.  Dynamic variability in SHP-1 abundance determines natural killer cell responsiveness.

Authors:  Zeguang Wu; Soo Park; Colleen M Lau; Yi Zhong; Sam Sheppard; Joseph C Sun; Jayajit Das; Grégoire Altan-Bonnet; Katharine C Hsu
Journal:  Sci Signal       Date:  2021-11-09       Impact factor: 8.192

2.  BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis.

Authors:  Timotheus Y F Halim; Rahul Roychoudhuri; Charlotte J Imianowski; Sarah K Whiteside; Teresa Lozano; Alexander C Evans; Jayme D Benson; Christina J F Courreges; Firas Sadiyah; Colleen M Lau; Nordin D Zandhuis; Francis M Grant; Martijn J Schuijs; Panagiota Vardaka; Paula Kuo; Elizabeth J Soilleux; Jie Yang; Joseph C Sun; Tomohiro Kurosaki; Klaus Okkenhaug
Journal:  J Exp Med       Date:  2022-09-30       Impact factor: 17.579

3.  IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma.

Authors:  Turan Aghayev; Aleksandra M Mazitova; Jennifer R Fang; Sergei I Grivennikov; Ekaterina K Koltsova; Iuliia O Peshkova; Matthew Rausch; Manhsin Hung; Kerry F White; Ricard Masia; Elizaveta K Titerina; Aliia R Fatkhullina; Isabelle Cousineau; Simon Turcotte; Dmitry Zhigarev; Anastasiia Marchenko; Svetlana Khoziainova; Petr Makhov; Yin Fei Tan; Andrew V Kossenkov; David L Wiest; John Stagg; Xin Wei Wang; Kerry S Campbell; Amiran K Dzutsev; Giorgio Trinchieri; Jonathan A Hill
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

Review 4.  NK Cells in the Human Lungs.

Authors:  Baptiste Hervier; Jules Russick; Isabelle Cremer; Vincent Vieillard
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 5.  The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review.

Authors:  Sarun Juengpanich; Liang Shi; Yasaman Iranmanesh; Jiang Chen; Zhenzhe Cheng; Aaron Kah-Jin Khoo; Long Pan; Yifan Wang; Xiujun Cai
Journal:  Transl Oncol       Date:  2019-06-06       Impact factor: 4.243

6.  Pregnancy-Induced Alterations in NK Cell Phenotype and Function.

Authors:  Mathieu Le Gars; Christof Seiler; Alexander W Kay; Nicholas L Bayless; Elina Starosvetsky; Lindsay Moore; Shai S Shen-Orr; Natali Aziz; Purvesh Khatri; Cornelia L Dekker; Gary E Swan; Mark M Davis; Susan Holmes; Catherine A Blish
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

7.  Soluble and Exosome-Bound α-Galactosylceramide Mediate Preferential Proliferation of Educated NK Cells with Increased Anti-Tumor Capacity.

Authors:  Arnika K Wagner; Ulf Gehrmann; Stefanie Hiltbrunner; Valentina Carannante; Thuy T Luu; Tanja I Näslund; Hanna Brauner; Nadir Kadri; Klas Kärre; Susanne Gabrielsson
Journal:  Cancers (Basel)       Date:  2021-01-15       Impact factor: 6.639

8.  TRPV4 induces apoptosis via p38 MAPK in human lung cancer cells.

Authors:  Yanyan Zhao; Jiaying Wang; Xuehui Liu
Journal:  Braz J Med Biol Res       Date:  2021-10-18       Impact factor: 2.590

Review 9.  Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer.

Authors:  J Obajdin; D M Davies; J Maher
Journal:  Clin Exp Immunol       Date:  2020-07-25       Impact factor: 4.330

10.  Peripheral blood transcriptome heterogeneity and prognostic potential in lung cancer revealed by RNA-Seq.

Authors:  Qi Zhang; Manchao Kuang; Haiyin An; Yajing Zhang; Kai Zhang; Lin Feng; Lei Zhang; Shujun Cheng
Journal:  J Cell Mol Med       Date:  2021-07-21       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.